U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693569) titled 'Collagenase Injection for Spasticity Management' on July 02.
Brief Summary: The overall goal is to investigate the effectiveness of a novel intervention - Collagenase injection, for spasticity management in patients with neurological impairments, such as stroke, brain injury, and spinal cord injury.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Spasticity
Intervention:
BIOLOGICAL: XIAFLEX Collagenase injection
Collagenase is an enzyme that breaks down collagen, which is a key component of connective tissue, such as fascia. XIAFLEX is an FDA-Approved collagenase for treatment of Dupuytren's contracture with ...